These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25074943)

  • 1. Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation.
    Crisafulli E; Guerrero M; Menéndez R; Huerta A; Martinez R; Gimeno A; Soler N; Torres A
    Respir Care; 2014 Oct; 59(10):1550-9. PubMed ID: 25074943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
    Postma DS; Roche N; Colice G; Israel E; Martin RJ; van Aalderen WM; Grigg J; Burden A; Hillyer EV; von Ziegenweidt J; Gopalan G; Price D
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1163-86. PubMed ID: 25378918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
    Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
    Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
    J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
    Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
    Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.
    O'Byrne PM; Rennard S; Gerstein H; Radner F; Peterson S; Lindberg B; Carlsson LG; Sin DD
    Respir Med; 2012 Nov; 106(11):1487-93. PubMed ID: 22902134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
    Larsson K; Janson C; Lisspers K; Jørgensen L; Stratelis G; Telg G; Ställberg B; Johansson G
    J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compare the efficacy of inhaled budesonide and systemic methylprednisolone on systemic inflammation of AECOPD.
    Sun X; He Z; Zhang J; Deng J; Bai J; Li M; Zhong X
    Pulm Pharmacol Ther; 2015 Apr; 31():111-6. PubMed ID: 25281894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study.
    Man SF; Xuekui Zhang ; Vessey R; Walker T; Lee K; Park D; Sin DD
    Ther Adv Respir Dis; 2009 Apr; 3(2):73-80. PubMed ID: 19465442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
    Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA
    Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients.
    Ozol D; Aysan T; Solak ZA; Mogulkoc N; Veral A; Sebik F
    Respir Med; 2005 Dec; 99(12):1494-500. PubMed ID: 15946834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease.
    Ding Z; Li X; Lu Y; Rong G; Yang R; Zhang R; Wang G; Wei X; Ye Y; Qian Z; Liu H; Zhu D; Zhou R; Zhu K; Ni R; Xia K; Luo N; Pei C
    Respir Med; 2016 Dec; 121():39-47. PubMed ID: 27888990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Corticosteroids for treatment of patients with chronic obstructive pulmonary disease].
    Nishimura K
    Nihon Rinsho; 2003 Dec; 61(12):2181-6. PubMed ID: 14674330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
    Fan VS; Bryson CL; Curtis JR; Fihn SD; Bridevaux PO; McDonell MB; Au DH
    Am J Respir Crit Care Med; 2003 Dec; 168(12):1488-94. PubMed ID: 14525798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.
    Sharafkhaneh A; Southard JG; Goldman M; Uryniak T; Martin UJ
    Respir Med; 2012 Feb; 106(2):257-68. PubMed ID: 22033040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
    Ernst P; Gonzalez AV; Brassard P; Suissa S
    Am J Respir Crit Care Med; 2007 Jul; 176(2):162-6. PubMed ID: 17400730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.